home / stock / prax / prax message board
Subject | By | Source | When |
---|---|---|---|
Despite Trial Failure Praxis Still Seeks Advancing Essential | ctb | investorshub | 03/03/2023 4:15:45 PM |
News today. | IPO$ | investorshub | 03/03/2023 4:14:25 PM |
Not looking good now. | IPO$ | investorshub | 03/03/2023 4:13:49 PM |
Getting killed this am. | IPO$ | investorshub | 03/03/2023 3:19:59 PM |
FDA phase 2 approval due in next week | IPO$ | investorshub | 03/01/2023 8:31:53 PM |
ATM offering on S-3 didnt hurt 2022 as | IPO$ | investorshub | 03/01/2023 8:31:29 PM |
Book value at 12/31/22 is $76M. Not bad. | IPO$ | investorshub | 03/01/2023 6:36:05 PM |
$61M cash at 12/31/22 with 49M shares O/S | IPO$ | investorshub | 03/01/2023 6:31:14 PM |
I wonder how much cash they have now? | IPO$ | investorshub | 03/01/2023 6:27:13 PM |
$PRAX has $5 a share cash and easily | ElCollector | investorshub | 06/15/2022 2:56:39 PM |
Looking for a gain. | rtrstock | investorshub | 03/22/2021 3:01:26 PM |
News, Short Squeeze, Breakout and More Instantly...
Praxis Precision Medicines Inc. Company Name:
PRAX Stock Symbol:
NASDAQ Market:
Praxis Precision Medicines Inc. Website:
2024-05-20 14:30:05 ET Piper Sandler analyst issues OVERWEIGHT recommendation for PRAX on May 20, 2024 12:01PM ET. The previous analyst recommendation was Overweight. PRAX was trading at $44.93 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-05-16 16:30:03 ET Jefferies analyst issues BUY recommendation for PRAX on May 16, 2024 02:01PM ET. The previous analyst recommendation was Buy. PRAX was trading at $45.32 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...